GGrantIndex
Sort

261,768 grants matching gene therapy

Immune modulation of radiation therapy with Flt3 ligand

$1,204,513
Tibor Keler · Celldex Therapeutics, Inc. · R44 · FY2020 · CA

Development of Gene-Silencing Therapeutics for Pseudomonas aeruginosa

$1,204,439
David Elihu Greenberg · Ut Southwestern Medical Center · R01 · FY2019 · AI

GENDER EFFECTS ON HIV BIOLOGY

$1,204,257
J. David Gladstone Institutes · P01 · FY2004 · HD

Integrative analysis and modeling of human immune responses and pathologies

$1,204,175
John Tsang · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI

Basic and Translational Research iPSC-based hematologic and vascular therapies

$1,204,118
John P Cooke · Stanford University · U01 · FY2012 · HL

Resource for Molecular Imaging Agents in Precision Medicine

$1,203,878
Martin G Pomper · Johns Hopkins University · P41 · FY2019 · EB

Rapid multiplex method for direct phenotypic ID/AST of bacterial pathogens

$1,203,777
Ian Fleming · Guild Associates, Inc. · R01 · FY2019 · AI

Ebola Vaccine Development

$1,203,749
Nancy J Sullivan · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI

UCLA Center for AIDS Research (CFAR)

$1,203,745
Jerome A. Zack · University Of California Los Angeles · P30 · FY2018 · AI

Resource for Molecular Imaging Agents in Precision Medicine

$1,203,600
Martin G Pomper · Johns Hopkins University · P41 · FY2020 · EB

SEARCH FOR SELECTIVE THERAPY OF CML

$1,203,466
Sloan-Kettering Institute For Cancer Res · P01 · FY2003 · CA

Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial

$1,203,374
Nisha Acharya · University Of California, San Francisco · UG1 · FY2021 · EY

Immuno/Immunogene Therapies for Thoracic Malignancies

$1,203,367
Steven Mark Albelda · University Of Pennsylvania · P01 · FY2009 · CA

FilmArray Direct: Rapid Diagnosis of Antimicrobial-Resistant Pathogens from Blood

$1,203,182
Andrew Hemmert · Biofire Diagnostics, Llc · R01 · FY2018 · AI

Understanding the dynamic interactions between tau pathology and microgliamediated inflammation in Alzheimer's Disease

$1,203,102
Ajay Gupta · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · AG

Repurposing antimalarials for the treatment of NTM infections

$1,203,091
Mary Jackson · Colorado State University · R01 · FY2025 · AI

Pediatric Oncology Branch Behavioral Science Core

$1,203,016
John Glod · Division Of Basic Sciences - Nci · ZID · FY2023 · CA

Leveraging DNA damage repair pathways as therapeutic targets in womens cancers

$1,202,994
Jung-Min Lee · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Regulation of Differentiation of Pediatric Embryonal Tumors- Neuroblastoma

$1,202,975
Carol Thiele-Galetto · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Leveraging biomarkers for personalized treatment of alcohol use disorder comorbid with PTSD

$1,202,962
Charles R Marmar · New York University School Of Medicine · P01 · FY2018 · AA

Novel Approach to High-Throughput Identification and Characterization of Neoantigen-Specific T-Cell Receptors to Guide Immunotherapy Development.

$1,202,794
Magali Soumillon · Flexomics Llc · R44 · FY2022 · CA

Leveraging biomarkers for personalized treatment of alcohol use disorder comorbid with PTSD

$1,202,772
Charles R Marmar · New York University School Of Medicine · P01 · FY2021 · AA

Leveraging biomarkers for personalized treatment of alcohol use disorder comorbid with PTSD

$1,202,772
Charles R Marmar · New York University School Of Medicine · P01 · FY2019 · AA

Leveraging biomarkers for personalized treatment of alcohol use disorder comorbid with PTSD

$1,202,772
Charles R Marmar · New York University School Of Medicine · P01 · FY2020 · AA

Core 3 - Immunobiology Core

$1,202,642
Derek Wilson Cain · Duke University · U54 · FY2023 · AI